Cancer Conference Update
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:52:52
- Mas informaciones
Informações:
Sinopsis
Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions. CME information and select publications here.
